Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Richard Huslig (NPI 1346215746)

Field	Value
Entity Type	Individual
Organization	Richard Huslig
Address	1734 York Road
City	Lutherville
State	MD
ZIP	21093
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	February 20, 2006

Payer Source	Total Paid
Medicare	$4.9M
Medicaid	$0

Key Findings

RICHARD HUSLIG is effectively a Medicare-focused Hematology & Oncology physician with $4.9M in total Medicare revenue and no Medicaid billing on file. The practice is single‑payer in scale for the observed dataset, making Medicare the dominant (and only reported) public payer for this provider’s revenue stream.

Revenue concentration is high: the precomputed top 3 Medicare codes by revenue account for 56.0% of this provider's total Medicare revenue, driven primarily by J9271 (34.8% of Medicare revenue), J0897 (11.0%), and J9299 (10.2%). This concentration indicates that a majority of Medicare dollars flow through a very small set of high-use injectable oncology/immunotherapy codes.

The code mix and descriptions point to an infusion-centric oncology practice: J9271 (pembrolizumab), J9299 (nivolumab), and multiple chemotherapy/infusion administration codes (96413, 96365, 96375, 96374, 96417) appear in the top 25, consistent with routine outpatient immunotherapy and chemotherapy delivery. Supportive care and biologic agents such as J0897 (denosumab), J2796 (romiplostim), J2506 (pegfilgrastim), and J0881 (darbepoetin alfa) further suggest integrated on-site management of cancer-related bone health, thrombocytopenia, and anemia.

Several individual codes show outsized national standing: J9271 ranks #38 of 1841 providers (98th percentile) and is described as notably above typical national volume; J0897 ranks #108 of 10057 providers (99th percentile) and is labeled an extreme outlier far above national volume; J2796 ranks #2 of 20 providers (95th percentile) and is notably above typical national volume. These rankings indicate the provider is a major national outlier for specific biologic and supportive care injections, signaling unusually high throughput for those medications.

Not all high-revenue drugs are outliers: J9299 (nivolumab) accounts for $478.1K (10.2% of Medicare revenue) but ranks #166 of 505 providers (67th percentile), noted as typical and unremarkable volume. This contrast—extreme/high outlier status for some agents and typical volumes for others—suggests selective concentration in certain drug therapies rather than uniformly high volumes across all immunotherapy agents.

High procedural throughput for infusion delivery is corroborated by administration code ranks: 96413 (816 claims) ranks #158 of 7514 providers (98th percentile) and 96365 (657 claims) ranks #226 of 8873 providers (97th percentile), both described as notably above typical national volume. These patterns support an operational model with substantial on-site infusion capacity and frequent chemotherapy/immunotherapy sessions.

Non-drug services also contribute meaningfully: 99214 office visits (1.7K claims, $165.7K revenue) rank #2476 of 479517 providers (99th percentile) and are described as an extreme outlier, indicating a high volume of established-patient E/M encounters relative to peers. Routine lab and monitoring services appear as well (e.g., 85025 CBC), consistent with active medical oncology follow-up and infusion monitoring workflows.

Tenure is long-standing: the NPI was enumerated on 2006-02-20 (~20 years ago), indicating the provider has been registered and potentially practicing for approximately two decades, which may support established referral relationships and sustained infusion program capacity over time.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

53 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	38,000	$40	$1.6M
J0897	Injection, denosumab, 1 mg	28,680	$20	$516.2K
J9299	Injection, nivolumab, 1 mg	19,920	$20	$478.1K
J2796	Injection, romiplostim, 10 micrograms	6,040	$70	$441.2K
J3380	Injection, vedolizumab, intravenous, 1 mg	14,400	$20	$244.8K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	6,480	$30	$213.7K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	4,900	$40	$176.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,690	$100	$165.7K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	75,150	$1	$150.3K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	3,040	$40	$106.4K

Showing 1–10 of 53

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 53 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

Richard Huslig — 10 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

53 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	5	60	15,000	$40	$787.6K
J9299	15	20	24,080	$20	$660.6K
J0129	21	40	6,060	$30	$290.2K
J2796	1	10	3,450	$70	$252.3K
J3380	7	20	10,650	$20	$213.3K
J1569	3	10	3,440	$40	$203K
Q5115	3	10	3,300	$30	$170.1K
J0897	5	340	3,600	$20	$114.4K
J1745	26	40	2,810	$30	$109K
J1602	12	30	8,300	$10	$102.8K

Showing 1–10 of 53

Related Providers

Other providers that share a Tax Identification Number (TIN) with Richard Huslig, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
St Paul Place Specialists, Inc.	MD	Dermatology Physician	$0	$13.3M
Michael Morris	MD	Diagnostic Radiology Physician	$12M	$0
St Paul Place Specialists, Inc.	MD	Clinical Pathology/Laboratory Medicine Physician	$2.7M	$948.8K
Panayotis Ledakis	MD	Hematology & Oncology Physician	$3M	$0
Jaideep Sohi	IL	Nuclear Radiology Physician	$1.5M	$6.9K
Kelly Orwat	SC	Internal Medicine Physician	$1.3M	$0
Jonathan Breslau	MN	Diagnostic Radiology Physician	$1.3M	$0
Muhammad Saad Khan	IL	Hematology & Oncology Physician	$1.3M	$0
Stephen Ronson	MD	Specialist	$1.2M	$0
Pavni Patel	MD	Nuclear Medicine Physician	$1.1M	$0

Nearby Providers

Other providers in the same ZIP code as Richard Huslig, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mosaic Community Services, Inc.	MD	Rehabilitation Clinic/Center	$0	$21.1M
Maxim Healthcare Services, Inc.	MD	Home Health Agency	$0	$18.4M
Stella Maris Inc.	MD	Community Based Hospice Care Agency	$0	$16.9M
Glass Health Programs, Inc.	MD	Substance Use Disorder Rehabilitation Clinic/Center	$479.3K	$8.7M
William Sharfman	MD	Medical Oncology Physician	$9.1M	$0
Mosaic Community Services, Inc.	MD	Adult Mental Health Clinic/Center	$0	$7.1M
Windrush Behavioral Health, LLC	MD	Specialist	$0	$7M
Psych Associates Of Maryland LLC	MD	Psychologist	$0	$5.8M
Katzen Medical Associates, PC	MD	Ophthalmology Physician	$0	$5.6M
Learning And Therapy Corner, LLC	MD	Speech-Language Pathologist	$0	$4.2M

Richard Huslig — Billing Profile & Reimbursement Data

Sign up for Richard Huslig — Billing Profile & Reimbursement Data policy alerts

Richard Huslig — Billing Profile & Reimbursement Data

Sign up for Richard Huslig — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References